While expression of intracellular adhesion molecule 1 (ICAM-1; CD54) is associated with chronic inflammation and autoimmune disease, and is also found on some tumours arising from ICAM-1-negative tissues, in apparently normal tissues it is restricted to a few cell types. Levels of constitutive ICAM-1 expression correlate with the levels of ICAM-1 mRNA. In order to identify regions of the gene regulating its constitutive expression, 5.8 kb of the 5' upstream region was studied in 16 human cell lines using transient transfection of reporter-gene constructs. Three enhancing and one silencing region were ob served. While the enhancer upstream of position -1352 was active in all cells investigated, the inhibitory influence of a silencer region between positions -339 and -290 was observed only in 50% of the cells.
cule.
The glycoprotein intercellular adhesion molecule 1 (ICAM-1, CD54) is a member of the immunoglobulin supergene family [1, 2] and a cell-adhesion molecule that serves as a counter-receptor for a number of molecules including the leuko cyte p2 integrins LFA-1 (CDlla) and MAC-1 (CDllb) and the T-cell leukosialin CD43 [3] [4] [5] [6] [7] [8] [9] . The interaction between LFA-1 and ICAM-1 is an important step in the development of immune responses, mediating the migration of lymphocytes into the tissues, playing a costimmulatory role in T-cell activation and strengthening interactions between effector cells and their targets [10] [11] [12] . While upregulation of ICAM-1 can be induced in essentially any cell type by exposure to cytokines, in normal tissues detectable constitutive ICAM-1 expression is restricted to lymphoid follicle germinal centres, some vascular endothelia and to occasional cells in thymus, tonsils and proximal tubules in the kidney [3,13 -16] . The association of high levels of endo thelial and epithelial ICAM-1 expression with a wide range of autoimmune diseases suggests that ICAM-1 plays an important role in the initiation and maintenance of these diseases [17] [18] [19] [20] . The expression of ICAM-1 on solid tumours derived from ICAM-1-negative tissues, appears to be largely independent of the degree of leukocyte infiltration and to be rather a question of the tumour type. Thus, ICAM-1 expression is frequent on malignant melanomas and renal cell carcinomas, is found only on a minority of gastric carcinomas and breast carcinomas and Correspondence to J. P. Johnson, Goethestr. 31, Germany Abbreviations. ICAM-1, intercellular adhesion molecule-1 ; RLU, relative light units; MFI, mean fluorescence intensity. very rarely on colorectal carcinomas [21] [22] [23] [24] . While the role of ICAM-1 expressed on tumours remains unclear, it has been shown in several cases to have a prognostic significance [21, 24] . Clearly, a better understanding of how constitutive ICAM-1 expression is regulated is important in the context of both auto immunity and host-tumour interactions. To understand how con stitutive ICAM-1 expression is controlled, reporter-gene con structs of the 5' regulatory region of the ICAM-1 gene have been transfected into various cell lines [28] [29] [30] [31] [32] . On the basis of studies on two cell lines, a silencing region that is active in ICAM-1-negative-cells, but inactive in ICAM-1-expressing cells has been reported [30] . In the study presented here, the expres sion of ICAM-1 promoter-region constructs have been charac terised in 16 human cell lines deriving from different tissues. Although this silencer activity was found in 50% of the cells, it did not correlate with either the ICAM-1 phenotype or the cell type. Furthermore, a constitutively enhancing region between positions -2400 and -1352 that could override the silencer, and two additional positively acting sites downstream of posi tion -277 were detected. A comparison of the activity of the 5' region in ICAM-1-positive and ICAM-1-negative cell lines suggests that two distinct patterns of constitutive ICAM-1 gene regulation exist; one that is active in cells expressing low levels of ICAM-1 and one that is active in cells that are either negative for ICAM-1 or express high levels of ICAM-1.
MATERIALS AND METHODS
Cell culture. Human cell lines were established in our labo ratory or obtained from the American Type Culture Collection, and were cultured in RPMI 1640 medium (Biochroin) contain ing 5% fetal calf serum, 1 mM sodium pyruvate, 2 mM 1-gluta mine, 100 li/ml streptomycin and 100 U/ml penicillin.
Immunofluorescence and FACScan analysis. The first antibody used was either P3.58BA-14 anti-ICAM-1 [33] or upc 10 myeloma protein (Sigma) as isotype control. The second anti-(mouse Ig) serum was fluoroisothiocyanate labelled (Dakopatts F261). The cells were examined under a fluorescence microscope and flow cytometry was performed using a FACS can (Becton Dickinson).
Northern-blot analysis. Total RNA was prepared using a modification of the caesium trifluoracetate method (Pharmacia). 20 |L ig RNA/lane were denatured in formaldehyde, separated on a 1.2% agarose/formaldehyde gel [34] , and transferred to a Hybond-N membrane (Amersham). The 690-bp 1CAM-1 cDNA Pstl fragment, labelled with [«-32P]dATP (Amersham) using random priming [35] , was used as a probe. Hybridisation and washing were carried out as described [21] . Hybridisation with an oligonucleotide (5' CCCTGGTGAC CAGGCGGCCA ATACGGCCAA TCCGTTGACT CCGACTTTCC AC 3') from the first exon of the glyceraldehyde-3-phosphate dehydrogenase gene [36] was used as an internal standard. The oligonucleotide was end-labelled with [a-32P]dATP (Amersham) using terminal dideoxynucleotidyl transferase (Gibco-BRL) and the membrane was hybridised at 68°C in 5 XNaCl/Cit (1 Xconsists of 150 mM sodium citrate, 15 mM NaCl, pH7.0)/10XDenhardt's solution/ 7% SDS/10 mM sodium phosphate, pH 7.0/10% dextran sul phate/100 ng/ml salmon sperm DNA. The membrane was washed first in 3 X NaCl/Cit/10 X Denhardt's solution/5 % SDS/ 10 mM sodium phosphate, pH 7.0, at the hybridisation temper ature, then in 1 X NaCl/Cit/1 % SDS at room temperature.
Construction and purification of luciferase reporter-gene plasmids. All constructs except pIC-5800, pIC-2400 and pIC-277JTATA1, have been described previously ( Fig. 1 B) [28] .
pIC-5800 was constructed by digestion of X clone PBL 11 ( Fig. 1 A; in [37] Table 1 oligonucleotides B and C were mistak enly shown as reactive) with Sail, isolation of the 5,8-kb frag ment and ligation with promoterless pXP-2 (kindly provided by S. K. Nordeen, Denver, USA) [38] , also cut with SalL The 2.4kb fragment was excised with Sail from X clone HWB 3R1 ( Fig. 1 A) and inserted into pXP-2. The fact that the clone was full length and in the correct orientation was confirmed by re striction enzyme digestion and sequencing of the cloning sites.
pIC-277zfTATAl was constructed by deleting the Nhel-Sstl fragment of pIC-277, then sequenced [28] . Plasmid DNA was purified by separation over two caesium chloride gradients [39] . To exclude transfection differences due to variability in DNA purification, at least two different batches were used in these studies.
Transient transfection and detection of luciferase activity of reporter-gene constructs. For transfection of the reportergene constructs, the Transferrinfection system (Serva) was used. 250000 cells were grown for 18 h in six-well plates (11 cm2, Falcon/Becton Dickinson). The supercoiled plasmid DNA (equimolar amounts of each plasmid made up to 12 jig total DNA with pXP-2) diluted in HBS (20 mM Hepes, 150 mM sodium chloride, pH 7.3) was complexed by the poly-(L)-lysine-ferrous conjugate (16 p.g/12 fig total DNA) for 30 min at room temper ature, in a total volume of 0.5 ml. This was added to the cells, together with 2 ml HBS medium containing 125 jliM chloroquine. Following 6 h exposure, the cells were rinsed once with warmed RPMI 1640 medium and incubated for a further 24 h in fresh RPMI 1640 medium. Cells were washed once with NaCl/ Pi (15 mM potassium dihydrogen phosphate, 80 mM disodium hydrogen phosphate, 139 mM NaCl, pH 7.2) and lysed with 125 |il lysis buffer of the luciferase assay system (Promega). 20 jil cell lysate was measured for 10 s in a luminometer (LB9501, Bertold Lumat) injecting 100 \ d luciferase assay reagent.
To standardise the measured relative light units (RLU), the protein content was determined according to the method of Bradford [40] using the Biorad protein assay reagent (Biorad). The standardised absolute luciferase activity was calculated by dividing the observed RLUs in 20 jil cell lysate by the protein content. Previous experiments had shown that correcting for the protein content gave rise to the same expression patterns as stan dardisation with the cotransfected plasmid CDM8/?Gal (kindly provided by A. Leutz, Berlin, Germany) and detection of /J-galactosidase activity. To avoid possible titration effects when using two promoter-containing plasmids, the protein standardi sation approach was routinely used. Each transfection was carried out in triplicate and at least three independent experi ments were performed.
Transfection of genomic clone HWB 3R1. Transfection using lipofectin (Gibco-BRL) was performed as described [37] , but using 5 fig X DNA. ICAM-1 expression was determined by immunofluorescence and immunoperoxidase staining. The highest ICAM-1 expression was observed on day 3 after trans fection.
Computer analysis. All published ICAM-1 sequences [29, 31, 32, 37] upstream of exon 1 were combined into one sequence extending from positions -1816 to +41 (the down stream transcription start site was set +1) [31] . Searches for consensus sequences in this ICAM-1 sequence were performed on a VAX/VMS machine with the GCG program package. Com parison of the transcription factors database (TFD, release 7.3) with the ICAM-1 sequence was performed on a Macintosh PC with the Macmolly program package.
RESULTS

Classification of human cell lines by their ICAM-1 expres sion.
ICAM-1 cell surface expression was evaluated using flow cytometry on 16 cell lines of diverse histological origin ( Table 1 ). The cells could be divided into three groups on the basis of their A mean fluorescence intensity (//MFI), i.e. MFI of anti-(ICAM-l) IgG binding minus MFI of isotype control bind ing: ICAM-1-negative cell lines (zfMFI<30), ICAM-1-positive cell lines (JMFI 30-200) and strongly ICAM-1-positive (¿iMFI>200). The fluorescence intensities of the negative con trol upclO (dotted line) and the anti ICAM-1 IgG (P3.58BA-14, solid line) are shown in Fig. 2 as examples of each of the three groups.
Northern-blot analysis confirmed that the cell surface levels of ICAM-1 reflect differences in steady-state mRNA levels and suggest that ICAM-1 expression is primarily regulated at the transcriptional level. As shown in Fig. 2C , cell lines 293, Colo320DM and H4 that show no ICAM-1 cell surface expres sion, express no detectable ICAM-1 mRNA. However, strongly positive cells Mel JuSo, A-375 and WM266-4 have high levels of mRNA, and the weakly positive cell line KATO expresses lower mRNA levels. exception of simian-vin.is-40-transformed fibroblast cell line HF/SV40, which was transfected only twice), using different DNA preparations. The measured luciferase activity (absolute expression, RLU/|ig protein) of plasmid pIC-174, containing the 174-bp ICAM-1 promoter region in front of the luciferase reporter-gene, is shown in Table L The absolute luciferase activ ity measured with pIC-174 differed greatly dependent on the cell line, however independent of the ICAM-1 expression. The luciferase-containing promoterless cloning vector, pXP-2 [38] , was used as a negative control. Its activity in all cell lines was below 5 RLU/jug protein and was not subtracted from test values. The luciferase expression of a set of deletion constructs of the ICAM-1 5' region was examined in each of the cells in Table 1 . The luciferase activity of pIC-174 was set at 100% rela tive expression, and compared to the other constructs, shown in Fig. 2 A and B for representative cell lines. In all cells examined, cells strongest luciferase expression was observed with construct pIC-5800 containing the longest 5" region of the ICAM-1 gene. Its activity was 1.2-2.5-fold higher than luciferase expression by pIC-174. Deletion of the region upstream of position -1352 resulted in decreased reporter-gene activity in all cells (only 0.5-0.125 of the activity of pIC-5800), suggesting that this re gion has an enhancing influence on ICAM-1 expression. Further deletion divided the investigated cell lines into two groups. The level of expression driven by the constructs spanning the region between positions -1352 and -339 was nearly constant in both groups but on different levels. In group-A cells ( Fig. 2A) , plas mids containing DNA upstream of position -174 and down stream of position -1352 generated luciferase expression that was reduced by at least 50% as compared to that of the pIC-174 plasmid. Type-B cells, in contrast ( Fig. 2B) , revealed nearly the same luciferase expression with plasmids spanning the entire region between positions -1352 and +1. These results indicate the presence of an inhibitory element between positions -339 and -174 that is active only in type-A cells. All cells in Table 1 were found to fall either into group A or group B (partially data not shown) and, comparing this characteristic with their ICAM-1 cell surface expression, revealed an unexpected correlation. All type-B cells (WM115, IgR37, KATO, BT20, SW403, LS180, HepG2 and HF/SV40) expressed low levels of ICAM-1. Table 1 . ICAM-1 cell surface expression and luciferase activity of construct pIC-174 in the examined human cell lines. z/MFT -difference MFI between ICAM-l-specific antibody and isotype control. ¿iMFI>30 was considered as positive, nnumber of independent experiments. RLU/ Hg protein ~ RLU/jig total protein. Lo Vo), were either strongly ICAM-1-positive or ICAM-1 nega tive.
Reporter-gene constructs reveal silencing and enhancing elements differentially active in cells with distinct ICAM-1 expression levels. To examine whether differences in the activ
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Cell line
Location of one silencing and three enhancing regions. By transfecting additional ICAM-1 5'-upstream-region constructs into the melanoma cell line Mel JuSo, the regulatory elements were localised. Mel JuSo is a strongly ICAM-1-positive type-A cell line (Table 1) , that shows the inhibitory influence of the region between positions -339 and -174 ( Fig. 3) . High luciferase expression was obtained with plasmids pIC-5800, containing 5.8 kb of the ICAM-1 5' upstream region, and pIC-2400 contain ing 2.4 kb of the ICAM-1 5' upstream region ( Fig. 3) . Deletion of the region upstream of position -1352 reduced activity to approximately 10% of that of pIC-2400, indicating an enhancer between positions -2400 and -1352 that is able to override the silencer downstream. While plasmids containing the ICAM-1 upstream region from positions -1352 to -339 showed an identical low level of reporter-gene activity, deletion of the region between posi tions -339 and -174 caused a fourfold increase of reportergene expression, similar to the expression patterns shown in Fig. 2A . This region was more closely examined using the con structs pIC-290/-6 and pIC-277 ( Fig. IB) . Deletion of the region from nucleodites -339 to -290, that includes the upstream TATA box [29] , caused a sevenfold increase in reporter-gene activity (Fig. 3 ), suggesting that the deleted region contains a binding site for the inhibitory element active in Mel JuSo. Deletion of a further 13 bp from positions -290 to -277 con taining a 12-O-tetradecanoylphorbol-13-acetate-responsive ele ment TRE [28] , caused no significant change in luciferase ex pression. It therefore appears that the inhibition of the reportergene expression mediated by the region between positions -339 and -174 is due to a silencer-binding site located between positions " 339 and -290. The sequence between positions -321 and -302 revealed homology to several known silencerbinding motifs ( Table 2 , see Discussion).
Deletion of the next 100 bp to position -174 still left an active promoter, but with a nearly twofold decreased activity in comparison to that of pIC-277. An internal deletion of posi tions -227 to -136 in pIC-277z/Sma had nearly no effect on the luciferase expression in comparison to that of pIC-277 ( Fig. 3 ), suggesting that the region ranging from positions -277 to -227 may be responsible for the enhanced expression j of pIC-277ziSma and pIC-277 relative to that of pIC-174. This site contains a putative AP-2 site at position -271 (GCCTGGCC) and a potential NF-/cB site at position -239 [41] .
'i Full activity of the core promoter depended on the presence i of the downstream TATA box (at -30 TATAAA) and the region between positions -108 and -34, containing putative Spl (-59 CCGCCC) and AP-2 (-48 CCCCCAGG) sites [41] . While pIC-277 showed full promoter activity, deletion of the region between positions -108 to -34 (pIC-277/lAP2) led to a nearly complete loss (more than 90%) of promoter activity with only slightly higher levels of luciferase activity than plasmid pIC-34, that contains only the downstream TATA box (Fig. 3) .
Deletion of the downstream TATA box from pIC-277 (con-* struct pIC-277JTATAl) reduced reporter-gene activity to back ground levels. However, promoter activity could be restored by the addition of sequences further upstream (plasmid pIC-1352zlTATAl), suggesting that the upstream TATA box at position -313 can also function as a transcription-initiation site (Fig. 3) .
The full-length clone mediates ICAM-1 expression in ICAM-1-negative cell lines.
HWB 3R1 is a full-length X clone, containing 15.5 kb of the human ICAM-1 gene including all seven exons, six introns, a 2.4-kb upstream region and a 1.5-kb 3' untranslated region ( Fig. 1 A) [37] . This clone was transfected into several ICAM-1-negative cell lines including H4, Colo320DM, 293 and HMCB. In all cell lines, ICAM-1-express ing cells were found both by immunofluorescence and by A immunoperoxidase staining (data not shown). No positive cells were observed following transfection of X DNA alone. Clone j HWB 3R1, therefore, contains all information necessary for functional ICAM-1 expression, however does not reflect the in vivo regulation. a few cell types [3, 13 -16] . However, strong ICAM-1 expres sion is found on some solid tumours [21] [22] [23] , As reported by Simmons et al. [1] and confirmed here, these different ICAM-1 protein levels reflect differences in ICAM-1 mRNA, indicating that this molecule is primarily regulated at the level of transcrip tion. Transient transfection of reporter-gene constructs revealed four regions that appear to be important and indicated that con stitutive expression is regulated in two different ways.
While human ICAM-1 expression can be induced on a vari ety of cell types in apparently normal tissues, it is restricted to
The highest levels of reporter-gene expression were ob served with the construct pIC-5800. Deletion of the region be tween positions -5800 and -1352 led to at least a 50% reduc tion in luciferase activity in all examined cell lines. Using addi tional constructs, the region mediating this enhancing effect was localised between positions -2400 and -1352, a region pre viously shown to contain a DNAsel hypersensitive region around position -1550. This site was reported in two ICAM-1- positive cell lines [32] , but is also detectable in the ICAM-1negative cell line LoVo (unpublished observations). An exami nation of the ICAM-1 sequence between positions -1816 and -1352 for potential transcription-factor-binding sites revealed, at position -1469 (GGGCAAGAGCT), homology to the re verse sequence of an antisilencer-binding site identified in the chicken vimentin gene (TGCCAAGAGCA) [42] as well as homology at position -1783 (CC ACC AC ACC) to an enhancer motif observed in the rat neu gene (GGTGGGGGGG) [43] .
Two potential NF-/cB-binding sites at position -1743 (GGGGTCTCCC) and position -1397 (GGGGCGTCCC), two possible Spl sites [positions -1452 (CCGCCC) and -1352 (GGCGGG)] and one putative AP-2 site at position -1415 (CCCAGGCC) were also identified in this region [41] .
Further deletion from -1352 to -339 bp led to little or no change in reporter-gene activity in the cells examined. In the so called type-B cells, deletion of the region between positions -339 and -174 also did not alter the luciferase activity. In con trast, in the type-A cells, deletion of this region led to an increase in luciferase expression up to fourfold, indicating the presence of an active silencer element. The silencing influence of this region has been shown previously [29] [30] [31] in different cells. On the basis of studies on one ICAM-1-positive cell line that lacked silencer activity and one ICAM-1-negative cell that demonstrated activity, Cornelius et al. [30] concluded that the region from positions -1163 to -277 correlates with the ICAM-1 phenotype and is necessary and sufficient to mediate constitutive ICAM-1 expression. The fact that we found an en hancer upstream of this silencer and the analysis of a large panel of positive and negative cells presented here clearly indicates that the two patterns of reporter-gene activity observed for the region between -339 and -174 bp do not correlate either with the cell type or with the absence or presence of ICAM-1 mRNA or protein. The analysis of additional constructs in Mel JuSo allowed the silencer region to be localised between positions -339 and -290. Computer-aided analysis of this region re vealed, around position -313, similarities to silencers found in a variety of different promoters (Table 2) , supporting the impor tance of this region. Although type-B cells generally expressed lower absolute levels of ICAM-1 promoter activity than type-A cells, a B-type pattern was also observed in cells with high abso lute activity (e.g. HepG2) and the type-A pattern was observed in cells with low promoter activity (e.g. A-375, H4 and HMCB), indicating that the pattern is not dependent on the absolute repor ter-gene activity.
Additional studies carried out in Mel JuSo (Fig. 3) revealed two further regions important in the regulation of the human ICAM-1 gene. The region between positions -277 and -227 ( Fig. 3 ) was found to enhance promoter activity by a factor of two in comparison to pIC-174. A search for transcription-factorbinding motifs in this region revealed the presence of a potential binding site for AP-2 and for NF-/cB [41] . Deletion of the DNA from positions -108 to -34, which contains consensus motifs for Spl and AP-2, led to a loss of greater than 90% of the promoter activity in Mel JuSo and, as previously described [28] , in cell line 293, suggesting an important role of Spl or AP-2 in regulating constitutive ICAM-1 expression. In-vitro binding assays did show specific binding of Spl to its putative site in all examined cell lines (unpublished observations), underscoring the importance of this region.
ICAM-1 contains two TATA boxes [29] . In Mel JuSo cells, both TATA boxes apparently can be used for the initiation of ICAM-1 transcription. Deletion of the upstream TATA box (Fig. 3 , pIC-339 compared to pIC-174) did not decrease the ex pression of luciferase reporter-gene constructs (in as far as this was detectable because of the overlapping silencer), indicating that transcription is mainly initiated from the downstream start site under constitutive conditions. However, deletion of the downstream TATA box (TATA1) from pIC-1352, a construct containing both TATA boxes, did not alter promoter activity (pIC-1352 compared to pIC-l352/ITATA1), indicating that, in Mel JuSo, the function of the downstream start site can be re placed by the upstream start site, and suggesting that the silencer functions not only via the downstream TATA box.
Although the presence or absence of an active silencer in the region from positions -339 to -290 could be used to divide the cells examined into two groups, this was not associated with ICAM-1 mRNA or cell surface protein expression. Nevertheless, a relationship between ICAM-1 expression and silencer activity was observed. Silencer activity was detectable only in cells that were ICAM-1 negative or that constitutively expressed high lev els of ICAM-1 (type-A cells). All of the cells that showed no silencer activity (type-B cells) expressed low but detectable lev els of ICAM-1. These results suggest that at least two distinct mechanisms are involved in the regulation of constitutive ICAM-1 expression. One mechanism, that appears to be associ ated with inactivity of the silencer region, leads to a low level of constitutive expression such as has been observed in a variety of cells in vivo and in vitro [3, 13 -16] and that may allow ICAM-1 to be rapidly upregulated by cytokines. The second is responsible for the high constitutive levels of ICAM-1, such as is found in macrophages and in some human tumours [21, 23, 24] , This regulation pattern is associated with the presence of an active silencer between positions -339 and -290 that is overridden by the enhancer binding between positions -2400 and -1352.
The transfected full-length 15.5-kb clone HWB 3R1, con taining all exons and introns, could be expressed in several ICAM-1-negative cell lines, suggesting that transcription factors acting on regions outside of HWB 3R1 are responsible for con stitutive expression, as shown for other genes [44, 45] . This could explain why we failed to identify the region conferring constitutive ICAM-1 expression. Clearly, interactions not imi tated by our in vitro system may also be involved. Jaiswal et al. [46] detected that limited amounts of tissue-specific factors can be easier titrated out in transient than in stable transfectants. An influence of balanced transcription factors were found in both multiple histocompatability complex class I, where a balance of positive and negative transcription factors seems to regulate its expression [47] , as well as in class II, where inhibition of tran scription is dependent on the amount of inhibitor D rl [48] . Pre liminary results (unpublished observations) suggest that DNA methylation, as observed in other genes [49, 50] , could partici pate in regulating constitutive ICAM-1 expression.
The studies reported here reveal important elements influ encing ICAM-1 expression and indicate that ICAM-1 is regu lated by a complex interaction between positive and negative elements. They also suggest that additional elements outside the examined region and features such as the methylation pattern play an important role in determining the constitutive expression of ICAM-1. This work was supported by a grant from the Deutsche Fors chungsgemeinschaft [Sonderforschungsbereich 217(A3) ].
